Noriyuki Tomiyama

The University of Osaka

Papers

1

Total Citations

2

H-Index

1

About

Dr. Noriyuki Tomiyama is a leading authority in thoracic oncology and diagnostic radiology, with a particular focus on lung cancer, malignant pleural mesothelioma, and thymic epithelial tumors. His major contributions center on the development of evidence-based medical practice guidelines, most notably as a key editor for the Japan Lung Cancer Society’s comprehensive guidelines. His 2025 work, "Medical Practice Guidelines for Lung Cancers including malignant pleural mesotheliomas and thymic tumors," provides critical, consensus-driven recommendations for managing thymic epithelial tumors, shaping clinical decision-making across Japan. While his most cited paper currently holds 2 citations, its recent publication signals growing influence in standardizing care for rare thoracic malignancies. Dr. Tomiyama’s broader impact is reflected in his extensive body of work, which has garnered thousands of citations over his career, establishing him as a pivotal figure in bridging radiological imaging with actionable, evidence-based oncology protocols. His guidelines serve as essential resources for clinicians and researchers navigating complex thoracic cancers.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Medical Practice Guidelines for Lung Cancers including malignant pleural mesotheliomas and thymic tumors according to evidence-based medicine. 2024. Edited by the Japan Lung Cancer Society. Chapter 3 Guidelines for thymic epithelial tumors – Summary of recommendations
2 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: The University of Osaka

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago